A Bioequivalence Study of Tobradex AF

NCT00362895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

995

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension
DRUG: Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)

Sponsor

Alcon Research